A global biopharmaceutical company markets a topical treatment for dermatological manifestations of a rare lymphoma, which can look like many other skin conditions, making it very difficult to diagnose. As a result, patients may struggle for many years without an accurate diagnosis, resulting in a sense of frustration for both the patient and the healthcare professional, who may only see 1-2 patients each year with the condition.
We pioneered a diverse program mix to educate multiple healthcare professional stakeholders involved in the diagnosis and delivery of care to patients suffering from these skin manifestations. The multi-faceted program included a strategy to develop a customer-facing content, refresh the brand look/feel, and drive healthcare professional recruitment. Using our proprietary WeConveen platform, we provided full-service speaker bureau set-up, training, logistics management, and related field support to implement all programs. Due to the successful ramp to onboarding and execution, we also established a program for another product in this client’s franchise. We now manage hundreds of on-going programs annually through WeConveen for them. Additionally, HCP media activity and analytics have been integrated into their WeConveen dashboards, including conference presence/participation – enabling the clients to centralize their view of all HCP engagement activities.